Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis

被引:0
|
作者
Zhang, Lei [1 ]
Zhang, Yan [1 ,2 ]
Zhang, Xu [1 ]
Hong, Baofa [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China
[2] 305 Hosp PLA, Dept Urol, Beijing, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2015年 / 8卷 / 11期
关键词
PTGS2; polymorphism; rs20417; prostate cancer; THERAPEUTIC IMPLICATIONS; GENETIC-VARIATION; CYCLOOXYGENASE-2; METAANALYSIS; EXPRESSION; COX-2; SUSCEPTIBILITY; PROLIFERATION; TECHNOLOGIES; PREVENTION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Genetic variation of SNPs in the PTGS2 gene is reported to be capable of creating tissue milieu favoring tumorigenesis. Some studies have implicated the common SNP rs20417 has association with PCa risk, while others showed reverse results. The study was performed with an aim to reconcile the existing controversy by performing a meta-analysis. Methods: We searched databases of Embase and PubMed and identified 8 publications fulfilling the specified inclusion criteria. X-2-based Q-test and I2 statistic were quantified to measure the heterogeneity across studies. The pooled ORs and 95% CIs were calculated to estimate the association between SNP rs20417 and PCa risk. Results: Based on an enlarged sample size by combining the data from published meta-analyses and those missed in them, the results of the present meta-analysis revealed the association of SNP rs20417 and overall PCa risk was not significant. Subgroup analyses according to ethnicity and source of controls did not show any significant results, either. Conclusions: The meta-analysis suggests that the presence of SNP rs20417 is unlikely to be associated with PCa risk. Our understanding of the genetic risk for PCa should be further expanded and refined through future research in a much larger number of participants.
引用
收藏
页码:20454 / 20462
页数:9
相关论文
共 50 条
  • [41] An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition
    Jason Ross
    Linda Lockett
    Diana Brookes
    Bruce Tabor
    Konsta Duesing
    Michael Buckley
    Trevor Lockett
    Peter Molloy
    Finlay Macrae
    Graeme Young
    Ignacio Blanco
    Gabriel Capella
    Garry N Hannan
    European Journal of Human Genetics, 2013, 21 : 1389 - 1395
  • [42] The Role of Luteolin in Inhibiting Prostaglandin-Endoperoxide Synthase 2 to Relieve Neointimal Hyperplasia in Arteriovenous Fistula
    Zhang, Ruibin
    Li, Wei
    Yang, Jihua
    Fan, Xiujie
    Fan, Huili
    Li, Wei
    ADVANCED BIOLOGY, 2025,
  • [43] Evidence for a Spatial and Temporal Regulation of Prostaglandin-Endoperoxide Synthase 2 Expression in Human Amnion in Term and Preterm Parturition
    Lee, Deug-Chan
    Romero, Roberto
    Kim, Jung-Sun
    Yoo, Wonsuk
    Lee, JoonHo
    Mittal, Pooja
    Kusanovic, Juan Pedro
    Hassan, Sonia S.
    Yoon, Bo Hyun
    Kim, Chong Jai
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (09) : E86 - E91
  • [44] Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis
    Li, Xiao-Dong
    Zi, Hao
    Fang, Cheng
    Zeng, Xian-Tao
    ONCOTARGET, 2017, 8 (27) : 44910 - 44916
  • [45] Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population
    Srivastava, Kshitij
    Srivastava, Anvesha
    Pandey, Sachchida Nand
    Kumar, Ashok
    Mittal, Balraj
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 774 - 780
  • [46] ASSOCIATION OF GENE POLYMORPHISM PTGS2 rs689466 WITH PLASMA IRISIN LEVEL IN YAKUTS
    Nikanorova, A. A.
    Barashkov, N. A.
    Pshennikova, V. G.
    Nakhodkin, S. S.
    Fedorova, S. A.
    YAKUT MEDICAL JOURNAL, 2023, (02): : 75 - 78
  • [47] Lack of association between the cyclooxygenase 2-765G>C polymorphism and prostate cancer risk: a meta-analysis
    Feng, Y. -Q.
    Li, Y. U.
    Xiao, W. -D.
    Wang, G. -X.
    Li, Y. O.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13391 - 13402
  • [48] PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
    Dossus, Laure
    Kaaks, Rudolf
    Canzian, Federico
    Albanes, Demetrius
    Berndt, Sonja I.
    Boeing, Heiner
    Buring, Julie
    Chanock, Stephen J.
    Clavel-Chapelon, Francoise
    Feigelson, Heather Spencer
    Gaziano, John M.
    Giovannucci, Edward
    Gonzalez, Carlos
    Haiman, Christopher A.
    Hallmans, Goran
    Hankinson, Susan E.
    Hayes, Richard B.
    Henderson, Brian E.
    Hoover, Robert N.
    Hunter, David J.
    Khaw, Kay-Tee
    Kolonel, Laurence N.
    Kraft, Peter
    Ma, Jing
    Le Marchand, Loic
    Lund, Eiliv
    Peeters, Petra H. M.
    Stampfer, Meir
    Stram, Dan O.
    Thomas, Gilles
    Thun, Michael J.
    Tjonneland, Anne
    Trichopoulos, Dimitrios
    Tumino, Rosario
    Riboli, Elio
    Virtamo, Jarmo
    Weinstein, Stephanie J.
    Yeager, Meredith
    Ziegler, Regina G.
    Cox, David G.
    CARCINOGENESIS, 2010, 31 (03) : 455 - 461
  • [49] Prostaglandin-endoperoxide synthase-2 deletion affects the natural trafficking of Annexin A2 in monocytes and favours venous thrombosis in mice
    Amadio, Patrizia
    Tarantino, Eva
    Sandrini, Leonardo
    Tremoli, Elena
    Barbieri, Silvia S.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (08) : 1486 - 1497
  • [50] Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: A meta-analysis
    Liu, Guoyuan
    Jiang, Deke
    Shen, Suqin
    Yu, Long
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (10) : 914 - 920